ABT-510 (acetate) [CAS 442526-87-6]
Partner: MedChemexpress LLC
| CAS No: | 442526-87-6 |
| Applications: | COVID-19-immunoregulation |
| MW: | 1054.28 |
| Formula: | C48H87N13O13 |
| SMILES: | N=C(N)NCCC[C@@H](C(N1CCC[C@H]1C(NCC)=O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CCC)NC([C@H]([C@H](O)C)NC([C@@H]([C@@H](C)CC)NC([C@H](C(C)C)NC(CNC(CN(C(C)=O)C)=O)=O)=O)=O)=O)=O)=O.CC(O)=O |
| Purity: | 99.49 |
| Description: | ABT-510 acetate is an anti-angiogenic TSP peptide (Thrombospondin-1 analogue) that induces apoptosis and inhibits ovarian tumour growth in an orthotopic, syngeneic model of epithelial ovarian cancer. ABT-510 acetate also reduces angiogenesis and inflammatory responses in a murine model of inflammatory bowel disease. ABT-510 acetate can be used in studies of cancer (particularly epithelial ovarian cancer) and inflammatory bowel disease (IBD)[1][2]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
